KR102632084B1 - Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract - Google Patents
Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract Download PDFInfo
- Publication number
- KR102632084B1 KR102632084B1 KR1020200171821A KR20200171821A KR102632084B1 KR 102632084 B1 KR102632084 B1 KR 102632084B1 KR 1020200171821 A KR1020200171821 A KR 1020200171821A KR 20200171821 A KR20200171821 A KR 20200171821A KR 102632084 B1 KR102632084 B1 KR 102632084B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- skin
- cucumber
- cosmetic composition
- cucumber grass
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 251
- 230000037303 wrinkles Effects 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 239000002537 cosmetic Substances 0.000 title claims abstract description 41
- 230000002087 whitening effect Effects 0.000 title claims abstract description 37
- 244000173853 Sanguisorba officinalis Species 0.000 title description 2
- 235000008282 Sanguisorba officinalis Nutrition 0.000 title description 2
- 230000003064 anti-oxidating effect Effects 0.000 title 1
- 240000008067 Cucumis sativus Species 0.000 claims abstract description 131
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims abstract description 120
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 102
- 230000006872 improvement Effects 0.000 claims abstract description 32
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 28
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 26
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 25
- 235000006708 antioxidants Nutrition 0.000 claims description 24
- 235000014066 European mistletoe Nutrition 0.000 claims description 23
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 23
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 23
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 23
- 240000006079 Schisandra chinensis Species 0.000 claims description 23
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 23
- 240000003768 Solanum lycopersicum Species 0.000 claims description 23
- 239000011782 vitamin Substances 0.000 claims description 23
- 229930003231 vitamin Natural products 0.000 claims description 23
- 235000013343 vitamin Nutrition 0.000 claims description 23
- 229940088594 vitamin Drugs 0.000 claims description 23
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000008513 turmeric extract Substances 0.000 claims description 14
- 229940052016 turmeric extract Drugs 0.000 claims description 14
- 235000020240 turmeric extract Nutrition 0.000 claims description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000000419 plant extract Substances 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 240000008620 Fagopyrum esculentum Species 0.000 claims 2
- 244000152640 Rhipsalis cassutha Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 41
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 abstract description 9
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 abstract description 9
- 102000003425 Tyrosinase Human genes 0.000 abstract description 9
- 108060008724 Tyrosinase Proteins 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 108010035532 Collagen Proteins 0.000 abstract description 4
- 102000008186 Collagen Human genes 0.000 abstract description 4
- 230000008099 melanin synthesis Effects 0.000 abstract description 4
- 239000005445 natural material Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 34
- 238000000605 extraction Methods 0.000 description 29
- 241000219051 Fagopyrum Species 0.000 description 21
- 241000221012 Viscum Species 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 239000000843 powder Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 241001180927 Trigonotis peduncularis Species 0.000 description 8
- 239000006143 cell culture medium Substances 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000012085 test solution Substances 0.000 description 8
- 238000002137 ultrasound extraction Methods 0.000 description 8
- 238000003809 water extraction Methods 0.000 description 8
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 7
- 108010050808 Procollagen Proteins 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 244000163122 Curcuma domestica Species 0.000 description 6
- 235000003392 Curcuma domestica Nutrition 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 235000003373 curcuma longa Nutrition 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 235000013976 turmeric Nutrition 0.000 description 6
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 5
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 5
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 5
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 5
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 4
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 4
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 4
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 4
- 101710200814 Melanotropin alpha Proteins 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010051246 Photodermatosis Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013553 cell monolayer Substances 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036564 melanin content Effects 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 2
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- -1 packs Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000010149 post-hoc-test Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
본 발명은 오이풀 추출물을 유효성분으로 포함하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물에 관한 것이다.
본 발명에 따른 항산화, 피부미백 및 피부주름 개선용 화장료 조성물은 천연 물질로 구성되어 피부에 안전하고, 우수한 피부미백 및 피부주름 개선 효과를 갖는다. 보다 구체적으로는 본 발명의 조성물은 멜라닌 합성 및 티로시나제 활성을 저해하여 피부미백에 효과적으로 작용하며, 피부주름의 생성에 직접적으로 작용하는 MMP-1의 발현을 효과적으로 억제하고, 콜라겐 단백질의 발현을 증가시켜 피부주름의 예방 및 개선에 효과적으로 작용한다. The present invention relates to a cosmetic composition for antioxidant, skin whitening, and skin wrinkle improvement containing cucumber grass extract as an active ingredient.
The cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement according to the present invention is composed of natural substances, is safe for the skin, and has excellent skin whitening and skin wrinkle improvement effects. More specifically, the composition of the present invention effectively acts on skin whitening by inhibiting melanin synthesis and tyrosinase activity, effectively inhibits the expression of MMP-1, which directly acts on the creation of skin wrinkles, and increases the expression of collagen protein. It works effectively in preventing and improving skin wrinkles.
Description
본 발명은 오이풀 추출물을 유효성분으로 포함하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement containing cucumber grass extract as an active ingredient.
최근 천연물 유래의 화장품에 관한 관심이 점점 커지고 있다. 또한 기능성 화장품에 대한 요구가 증가하면서 기능성 성분으로 사용되는 각종 화학성분들로 인하여 오히려 피부의 보호능력이나 재생능력이 저하되는 문제가 발생하고 있다. 이에 따라 스킨, 로션을 비롯해 색조 화장품에 이르기까지 천연물 소재의 화장품을 직접 만들어 사용하는 것이 유행하고 있기도 하다. 아토피 등의 피부질환을 가지고 있거나, 민감성 피부를 가진 사람들의 경우에는 피부 자극을 최소화하면서 피부 개선활성이 우수한 천연물 유래의 화장품에 대한 관심이 더욱 높아지고 있다. Recently, interest in cosmetics derived from natural products is growing. In addition, as the demand for functional cosmetics increases, the problem of the skin's protective ability and regenerative ability being reduced due to various chemical ingredients used as functional ingredients is occurring. Accordingly, it is becoming popular to make and use cosmetics made from natural materials, ranging from toners and lotions to color cosmetics. In the case of people with skin diseases such as atopy or sensitive skin, interest in cosmetics derived from natural products that minimize skin irritation and have excellent skin improving activity is increasing.
본 발명자들은 독성이 없고 항산화, 피부미백 및 피부주름 개선 효과가 우수한 천연소재에 대하여 연구를 수행하였으며, 오이풀 추출물이 우수한 항산화, 피부미백 및 피부주름 개선 효과를 나타낸다는 사실을 발견하였다. 또한, 상기 오이풀 추출물에 대한 연구를 계속하던 중, 오이풀을 겨우살이, 비타민나무열매, 오미자, 토마토 및 메밀과의 복합 추출물로 이용하는 경우 피부미백 및 피부주름 개선 효과가 더욱 좋아질 뿐만 아니라 우수한 항산화 효과를 나타낸다는 사실을 발견함으로써 본 발명을 완성하였다. The present inventors conducted research on natural materials that are non-toxic and have excellent antioxidant, skin whitening, and skin wrinkle improvement effects, and discovered that cucumber grass extract exhibits excellent antioxidant, skin whitening, and skin wrinkle improvement effects. In addition, while continuing research on the cucumber grass extract, when cucumber grass was used as a complex extract with mistletoe, vitamin tree fruit, Schisandra chinensis, tomato, and buckwheat, not only did the skin whitening and skin wrinkle improvement effects improve, but it also showed excellent antioxidant effects. The present invention was completed by discovering the fact that
본 발명의 해결하고자 하는 과제는 오이풀 추출물을 유효성분으로 포함하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물을 제공하는 것이다.The problem to be solved by the present invention is to provide a cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement containing cucumber grass extract as an active ingredient.
상기한 목적을 달성하기 위하여 본 발명은 오이풀 추출물을 유효성분으로 포함하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement containing cucumber grass extract as an active ingredient.
본 발명의 일 실시예에 의하면, 상기 추출물은 열수 추출물, 초음파 추출물 또는 락토바실러스속 유산균 발효물의 추출물일 수 있다. According to one embodiment of the present invention, the extract may be a hot water extract, an ultrasonic extract, or an extract of fermented lactic acid bacteria of the Lactobacillus genus.
본 발명의 일 실시예에 의하면, 상기 추출물은 오이풀에 자외선 UVB를 350 ~ 1000 mJ/cm2로 조사한 후 추출한 추출물일 수 있다. According to one embodiment of the present invention, the extract may be an extract extracted after irradiating cucumber grass with ultraviolet UVB at 350 to 1000 mJ/cm 2 .
본 발명의 일 실시예에 의하면, 상기 조성물은 상기 추출물을 5 내지 200 ㎍/mL 농도로 포함하는 것일 수 있다.According to one embodiment of the present invention, the composition may include the extract at a concentration of 5 to 200 μg/mL.
본 발명의 일 실시예에 의하면, 상기 조성물은 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 더 포함할 수 있다.According to one embodiment of the present invention, the composition may further include mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract.
본 발명의 일 실시예에 의하면, 상기 조성물은 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물이 1 : 0.5-2.0 : 0.5-2.0 : 0.1-1.5 : 0.05-1.0 : 0.05-1.0의 중량비로 포함된 것일 수 있다.According to one embodiment of the present invention, the composition contains cucumber grass extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract in the ratio of 1: 0.5-2.0: 0.5-2.0: 0.1-1.5: 0.05-1.0: It may be included at a weight ratio of 0.05-1.0.
본 발명의 일 실시예에 의하면, 상기 조성물은 상기 추출물 총 중량에 대하여 5 내지 15 중량부의 울금 추출물을 더 포함하는 것일 수 있다.According to one embodiment of the present invention, the composition may further include 5 to 15 parts by weight of turmeric extract based on the total weight of the extract.
본 발명의 일 실시예에 의하면, 상기 화장료 조성물은 화장수, 유액, 크림, 에센스, 화장 연고, 스프레이, 젤, 팩, 선 스크린, 메이크업 베이스, 파운데이션, 파우더 및 메이크업 제거제 중에서 선택되는 제형일 수 있다.According to one embodiment of the present invention, the cosmetic composition may be a formulation selected from lotions, emulsions, creams, essences, cosmetic ointments, sprays, gels, packs, sunscreens, makeup bases, foundations, powders, and makeup removers.
본 발명에 따른 항산화, 피부미백 및 피부주름 개선용 화장료 조성물은 천연 물질로 구성되어 피부에 안전하고, 우수한 피부미백 및 피부주름 개선 효과를 갖는다. 보다 구체적으로는 본 발명의 조성물은 멜라닌 합성 및 티로시나제 활성을 저해하여 피부미백에 효과적으로 작용하며, 피부주름의 생성에 직접적으로 작용하는 MMP-1의 발현을 효과적으로 억제하고, 콜라겐 단백질의 발현을 증가시켜 피부주름의 예방 및 개선에 효과적으로 작용한다. The cosmetic composition for antioxidant, skin whitening, and skin wrinkle improvement according to the present invention is composed of natural substances, is safe for the skin, and has excellent skin whitening and skin wrinkle improvement effects. More specifically, the composition of the present invention effectively acts on skin whitening by inhibiting melanin synthesis and tyrosinase activity, effectively inhibits the expression of MMP-1, which directly acts on the creation of skin wrinkles, and increases the expression of collagen protein. It works effectively in preventing and improving skin wrinkles.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 일 구현예에 따르면, 본 발명은 오이풀 추출물을 유효성분으로 포함하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물을 제공한다. According to one embodiment of the present invention, the present invention provides a cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement containing cucumber grass extract as an active ingredient.
상기 오이풀(Sanguisorba officinalis L.)은 쌍떡잎식물 이판화군 장미목 장미과의 여러해살이풀로 잎을 자르면 상큼한 오이냄새가 나기 때문에 오이풀이라고 한다. 굵은 뿌리줄기에서 갈라진 뿌리는 양끝이 뾰족한 원기둥 모양으로 굵어지고 원대는 곧게 1m 정도 자라며 위에서 가지가 갈라진다. 잎은 마디마다 서로 어긋나게 자리하고 있으며 깃털 모양의 겹잎으로 홀수의 잎 조각을 가진다. 일반적으로 잎은 길쭉한 타원형으로 생겼고 끝이 무디며 가장자리에 거친 톱니를 가진다. 꽃은 7~9월에 피고 검붉은색이며 수상꽃차례에 달린다. 꽃이삭은 타원형 또는 거꾸로 선 달걀모양의 타원형이며 위에서부터 꽃이 피기 시작한다. 열매는 수과로 10월에 익고 사각형이며 꽃받침으로 싸여 있다. The cucumber plant ( Sanguisorba officinalis L. ) is a perennial plant of the Rosaceae family of the dicotyledonous plant dicotyledon group, and is called cucumber plant because it emits a refreshing cucumber smell when the leaves are cut. The roots branched off from the thick rhizome become thick in the shape of a cylinder with sharp ends, and the stem grows straight up to about 1m, with branches branching at the top. The leaves are located alternately at each node and are feather-shaped compound leaves with an odd number of leaf segments. In general, leaves are elongated oval-shaped, have blunt ends, and have rough sawtooth edges. The flowers bloom from July to September, are dark red, and hang on water inflorescences. The flower spike is oval or inverted egg-shaped, and flowers begin to bloom from the top. The fruit is an achene, ripens in October, is square, and is surrounded by a calyx.
상기 오이풀 추출물은 오이풀의 꽃, 잎, 줄기, 열매, 종자, 뿌리 및 전초를 포함하는 군으로부터 선택되는 1 종 이상의 부위를 추출한 추출물일 수 있고, 오이풀의 뿌리를 추출한 것이 가장 바람직하며, 상기 오이풀의 뿌리는 지유로 지칭할 수 있다.The cucumber plant extract may be an extract obtained by extracting one or more parts selected from the group including flowers, leaves, stems, fruits, seeds, roots, and outposts of the cucumber plant. Most preferably, the root of the cucumber plant is extracted, and the extract of the cucumber plant is The root can be referred to as Jiyu.
상기 오이풀 추출물은 열수 추출, 침지 추출, 환류냉각 추출, 발효 후 추출 및 초음파 추출 등 당업계의 통상적인 방법을 이용하여 추출한 것일 수 있으나, 열수 추출, 초음파 추출 및 발효 후 추출 중에서 선택되는 하나의 방법을 이용하여 추출한 것이 효능 면에서 바람직하다. The cucumber grass extract may be extracted using a conventional method in the art, such as hot water extraction, immersion extraction, reflux cooling extraction, post-fermentation extraction, and ultrasonic extraction, but a method selected from hot water extraction, ultrasonic extraction, and post-fermentation extraction. Extraction using is preferable in terms of efficacy.
상기 오이풀은 추출용매와 1 : 10 내지 30, 바람직하게는 1 : 15 내지 25, 더욱 바람직하게는 1 : 18 내지 22의 중량비로 혼합하여 추출하는 것이 바람직하다. The cucumber grass is preferably extracted by mixing it with an extraction solvent at a weight ratio of 1:10 to 30, preferably 1:15 to 25, more preferably 1:18 to 22.
구체적으로, 상기 오이풀 열수 추출물은 추출 용매로서 40 ℃ 내지 100 ℃의 열수를 사용할 수 있고, 바람직하게는 65 내지 95 ℃의 열수를 사용할 수 있으며, 더욱 바람직하게는 85 내지 95 ℃의 열수를 사용할 수 있으나, 이에 한정되지 않는다. 또한, 추출시간은 1 내지 50 시간인 것이 바람직하며, 구체적으로 2 내지 20 시간이 더욱 바람직하고, 보다 구체적으로 2 내지 10 시간이 가장 바람직하나 이에 한정하지 않는다. 상기 오이풀과 추출용매의 중량비가 상기 범위를 벗어나는 경우에는 추출물에 오이풀의 유효성분이 적은 양으로 추출될 수 있다.Specifically, the cucumber grass hot water extract can use hot water at 40 ℃ to 100 ℃ as an extraction solvent, preferably hot water at 65 ℃ to 95 ℃, more preferably hot water at 85 ℃ to 95 ℃. However, it is not limited to this. In addition, the extraction time is preferably 1 to 50 hours, more specifically 2 to 20 hours, and more specifically 2 to 10 hours, but is not limited thereto. If the weight ratio of the cucumber grass and the extraction solvent is outside the above range, the active ingredient of the cucumber grass may be extracted in a small amount in the extract.
그리고, 상기 오이풀 초음파 추출물은 추출 용매로서 물, C1 내지 C4 저급 알코올 또는 이들의 혼합물을 사용하여 초음파 추출한 것일 수 있다. 상기 저급알코올로는 20 내지 80%의 메탄올, 에탄올, 부탄올 또는 프로판올을 들 수 있다. 상기 초음파 추출물의 추출용매로는 특별히 한정하는 것은 아니지만 60 내지 80%의 에탄올 수용액으로 추출된 초음파 추출물이 항산화, 피부미백 및 피부주름 개선에 바람직하게 작용한다.In addition, the ultrasonic extract of cucumber grass may be extracted ultrasonically using water, C 1 to C 4 lower alcohol, or a mixture thereof as an extraction solvent. The lower alcohol may include 20 to 80% methanol, ethanol, butanol, or propanol. The extraction solvent for the ultrasonic extract is not particularly limited, but the ultrasonic extract extracted with a 60 to 80% ethanol aqueous solution is preferred for antioxidant, skin whitening, and skin wrinkle improvement.
또한, 상기 오이풀 발효물의 추출물은 오이풀 발효물을 원심분리한 후 얻은 상등액, 또는 오이풀 발효물에 추출 용매를 가한 후 추출한 추출물일 수 있으나, 오이풀 발효물을 원심분리한 후 얻은 상등액인 것이 효능 면에서 더욱 바람직하다. 상기 오이풀 발효물은 오이풀 또는 오이풀 추출물을 유산균으로 발효하여 얻을 수 있으며, 바람직하게는 락토바실러스 람노서스 HK-9(기탁번호: KCCM11254P)로 발효시켜 수득할 수 있다. 구체적으로, 상기 오이풀 발효물은 락토바실러스 람노서스 HK-9를 적정한 양, 예를 들면 1 × 108 내지 5 × 109 cfu/mL 농도로 접종한 후, 25 내지 45 ℃에서 36 내지 60 시간 동안, 바람직하게는 30 내지 40 ℃에서 40 내지 55 시간 동안 발효시켜 수득한 것일 수 있다. In addition, the extract of the fermented cucumber grass may be a supernatant obtained after centrifuging the fermented product of cucumber grass, or an extract extracted after adding an extraction solvent to the fermented product of cucumber grass. However, in terms of efficacy, the supernatant obtained after centrifuging the fermented product of cucumber grass It is more desirable. The fermented cucumber grass product can be obtained by fermenting cucumber grass or cucumber grass extract with lactic acid bacteria, preferably by fermenting it with Lactobacillus rhamnosus HK-9 (Accession Number: KCCM11254P). Specifically, the cucumber grass fermentation product was inoculated with Lactobacillus rhamnosus HK-9 in an appropriate amount, for example, at a concentration of 1 × 10 8 to 5 × 10 9 cfu/mL, and then incubated at 25 to 45 ° C. for 36 to 60 hours. , preferably obtained by fermentation at 30 to 40°C for 40 to 55 hours.
본 명세서에서 오이풀을 언급하면서 사용되는 용어 "추출물"은 추출용매를 처리하여 얻은 조추출물뿐만 아니라 오이풀 추출물의 가공물도 포함한다. 예를 들어, 오이풀 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다. The term "extract" used herein when referring to cucumber grass includes not only the crude extract obtained by treatment with an extraction solvent, but also processed products of cucumber grass extract. For example, cucumber plant extract can be prepared in powder form by additional processes such as reduced pressure distillation and freeze-drying or spray drying.
본 발명의 바람직한 일 구체예에서, 상기 오이풀 추출물은 오이풀에 자외선 UVB를 350 ~ 1000 mJ/cm2, 바람직하게는 600 내지 950 mJ/cm2, 더욱 바람직하게는 800 내지 900 mJ/cm2로 조사한 후 추출한 추출물일 수 있다. 오이풀을 상기 범위의 조사량으로 자외선 UVB 조사한 후 추출하는 경우 오이풀 추출물의 피부미백 및 피부주름 개선 효능이 더욱 좋아진다. 만약, 상기 자외선 UVB의 조사량이 상기 하한치 미만인 경우에는 자외선 조사의 효과가 미미해지고, 상기 상한치를 초과하는 경우에는 오이풀 추출물의 피부미백 및 피부주름 개선 효능이 오히려 감소할 수 있다. In a preferred embodiment of the present invention, the cucumber grass extract is obtained by irradiating cucumber grass with ultraviolet UVB at 350 to 1000 mJ/cm 2 , preferably 600 to 950 mJ/cm 2 , and more preferably 800 to 900 mJ/cm 2 It may be an extract obtained after extraction. When extracting cucumber grass after irradiating it with ultraviolet UVB radiation in the above range, the skin whitening and skin wrinkle improvement effects of the cucumber grass extract are further improved. If the irradiation amount of ultraviolet UVB is less than the lower limit, the effect of ultraviolet irradiation becomes insignificant, and if it exceeds the upper limit, the skin whitening and skin wrinkle improvement efficacy of the cucumber grass extract may actually decrease.
본 명세서에서 용어 "유효성분으로 포함하는"이란 오이풀 추출물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 본 발명의 화장료 조성물은 상기 오이풀 추출물을 5 내지 200 ㎍/mL, 바람직하게는 5 내지 100 ㎍/mL, 더욱 바람직하게는 5 내지 50 ㎍/mL, 더욱 바람직하게는 5 내지 20 ㎍/mL 농도로 포함될 수 있다. 본 발명의 오이풀 추출물의 농도가 상기 하한치 미만인 경우에는 항산화, 피부미백 및 피부주름 개선 효과가 원하는 정도로 나타나지 않을 수 있고, 상기 상한치를 초과하는 경우에는 농도가 증가하는 만큼 항산화, 피부미백 및 피부주름 개선 효과가 증가하지 않거나 독성이 있을 수 있어 바람직하지 않다. 한편, 인 비트로 실험 결과, 본 발명의 오이풀 추출물의 농도가 상기 범위인 경우에는 항산화, 피부미백 및 피부주름 개선에 대하여 유의적인 효과가 나타나면서도 세포독성 등의 부작용이 나타나지 않았다. As used herein, the term “including as an active ingredient” means containing an amount sufficient to achieve the efficacy or activity of the cucumber grass extract. The cosmetic composition of the present invention contains the cucumber extract at a concentration of 5 to 200 μg/mL, preferably 5 to 100 μg/mL, more preferably 5 to 50 μg/mL, and even more preferably 5 to 20 μg/mL. may be included. If the concentration of the cucumber grass extract of the present invention is less than the lower limit, the antioxidant, skin whitening, and skin wrinkle improvement effects may not be achieved to the desired extent, and if it exceeds the upper limit, the antioxidant, skin whitening, and skin wrinkle improvement effects increase as the concentration increases. It is undesirable because it may not increase the effectiveness or may be toxic. Meanwhile, as a result of in vitro experiments, when the concentration of the cucumber grass extract of the present invention was within the above range, significant effects were observed for antioxidant, skin whitening, and skin wrinkle improvement, but no side effects such as cytotoxicity were observed.
본 발명의 화장료 조성물은 오이풀 추출물을 유효성분으로 포함하여 미백 효과를 발휘할 수 있으며, 보다 구체적으로는 상기 오이풀 추출물로부터 유래한 미백 활성 성분을 유효성분으로 포함하므로, 현저한 티로시나제 활성 억제 효과를 나타내어 멜라닌 생합성 억제 효과를 나타낼 수 있다.The cosmetic composition of the present invention contains cucumber grass extract as an active ingredient and can exert a whitening effect. More specifically, since it contains a whitening active ingredient derived from the cucumber grass extract as an active ingredient, it exhibits a significant tyrosinase activity inhibition effect, thereby inhibiting melanin biosynthesis. It may have an inhibitory effect.
본 발명의 일 구현예에 있어서, 상기 피부주름은 광노화 또는 자연노화에 의한 것일 수 있고, 광노화에 의한 것이 보다 바람직하며, UV 노출에 의한 광노화인 것이 더욱 바람직하지만 이에 한정되는 것은 아니다. 상기 피부주름은 MMP 효소의 활성을 기반으로 하는 것이 바람직하지만 이에 한정되는 것은 아니다. 일반적으로, UV 노출 후 피부의 주요 구성물질인 콜라겐을 분해하는 효소인 MMP의 발현 및 활성 증가로 인하여 피부주름 생성이 촉진된다. In one embodiment of the present invention, the skin wrinkles may be caused by photoaging or natural aging, more preferably photoaging, and more preferably photoaging due to UV exposure, but are not limited thereto. The skin wrinkles are preferably based on the activity of MMP enzymes, but are not limited thereto. In general, the formation of skin wrinkles is promoted after UV exposure due to an increase in the expression and activity of MMP, an enzyme that decomposes collagen, a major component of the skin.
또한, 상기 오이풀 추출물을 유효성분으로 포함하는 화장료 조성물은 타입 I 프로콜라겐 단백질의 발현을 증가시키고, MMP-1 단백질의 발현을 억제하는 것을 특징으로 한다.In addition, the cosmetic composition containing the cucumber grass extract as an active ingredient is characterized by increasing the expression of type I procollagen protein and inhibiting the expression of MMP-1 protein.
구체적으로, 본 발명의 상기 오이풀 추출물을 포함하는 화장료 조성물은 콜라겐 분해를 촉진시키는 기질 단백질 분해효소-1(matrix metallo-proteinase)의 발현을 억제시키면서, 타입 Ⅰ 프로콜라겐의 생성을 증가시키는바, 피부 탄력 증가, 피부 재생, 피부 주름 개선, 상처 치유, 손상된 피부 조직의 수복 및 재생; 및 피부 노화 방지 등의 효과 등을 가질 수 있다. 즉, 피부주름의 예방 또는 개선의 효과를 가질 수 있다.Specifically, the cosmetic composition containing the cucumber grass extract of the present invention inhibits the expression of matrix metallo-proteinase-1, which promotes collagen decomposition, while increasing the production of type I procollagen, thereby improving the skin Increased elasticity, skin regeneration, improvement of skin wrinkles, wound healing, repair and regeneration of damaged skin tissue; and may have effects such as preventing skin aging. In other words, it can have the effect of preventing or improving skin wrinkles.
본 발명의 피부주름 개선용 화장료 조성물에 포함된 오이풀 추출물은 그 자체로 피부주름을 제거하는 효과가 있으며, 기존에 알려진 피부 주름 개선에 효과가 있다고 공지된 물질들과 혼합하여 사용하는 경우에도 피부 주름의 예방 또는 개선 효과를 지속적으로 유지할 수 있다.The cucumber grass extract contained in the cosmetic composition for improving skin wrinkles of the present invention has the effect of removing skin wrinkles by itself, and even when mixed with substances known to be effective in improving skin wrinkles, The prevention or improvement effect can be maintained continuously.
본 발명의 바람직한 일 구체예에서, 상기 화장료 조성물은 상기 오이풀 추출물 외에 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 더 포함하는 혼합 추출물을 유효성분으로 할 수 있다. In a preferred embodiment of the present invention, the cosmetic composition may contain as an active ingredient a mixed extract further comprising mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract in addition to the cucumber grass extract.
본 명세서에서 용어 "혼합 추출물"은 1) 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 혼합 형태, 또는 2) 오이풀, 겨우살이, 비타민나무열매, 오미자, 토마토 및 메밀을 먼저 혼합한 후 이를 추출한 형태를 의미한다. 상기 혼합 추출물은 상기 1) 번과 같이 각각의 추출물을 따로 제조한 후 혼합하여 제조하는 것이 항산화, 피부미백 및 피부주름 개선 효능 면에서 더욱 바람직하다. 상기 각각의 추출물은 상기 오이풀 추출물과 동일한 방법으로 추출한 것일 수 있다. In this specification, the term "mixed extract" refers to 1) a mixed form of cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract, or 2) cucumber grass, mistletoe, vitamin tree fruit, Schisandra chinensis, tomato, and buckwheat. It refers to a form in which the mixture is first mixed and then extracted. It is more preferable to prepare the mixed extract by preparing each extract separately and then mixing them as in 1) above in terms of antioxidant, skin whitening, and skin wrinkle improvement effects. Each of the above extracts may be extracted in the same manner as the cucumber grass extract.
본 발명의 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 혼합 추출물은 추출물들 간의, 및/또는 추출물 내 유효성분들 간의 상승효과 또는 협업작용에 의하여 상기 각각의 식물의 단독 추출물에 비해 더욱 강력한 피부미백 및 피부주름 효능이 있음을 확인하였다. The mixed extract of cucumber grass extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract of the present invention is a synergistic or collaborative effect between the extracts and/or the active ingredients in the extract. It was confirmed that it had more powerful skin whitening and skin wrinkle effects compared to the single extract.
본 발명의 바람직한 일 구체예에서, 상기 화장료 조성물은 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물이 1 : 0.5-2.0 : 0.5-2.0 : 0.1-1.5 : 0.05-1.0 : 0.05-1.0의 중량비, 바람직하게는 1 : 0.5-1.5 : 0.5-1.5 : 0.1-1.0 : 0.1-0.5 : 0.1-0.5의 중량비, 더욱 바람직하게는 1 : 0.7-1.3 : 0.7-1.3 : 0.3-0.7 : 0.1-0.4 : 0.1-0.4의 중량비, 더욱 바람직하게는 1 : 0.8-1.2 : 0.8-1.2 : 0.4-0.6 : 0.2-0.3 : 0.2-0.3의 중량비로 포함된 것일 수 있다. 각 추출물의 중량비가 상기 범위일 때 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 병용에 따른 상승효과를 극대화할 수 있다. In a preferred embodiment of the present invention, the cosmetic composition contains cucumber grass extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract in a ratio of 1:0.5-2.0:0.5-2.0:0.1-1.5:0.05-1.0. :0.05-1.0, preferably 1:0.5-1.5:0.5-1.5:0.1-1.0:0.1-0.5:0.1-0.5, more preferably 1:0.7-1.3:0.7-1.3:0.3- It may be included in a weight ratio of 0.7:0.1-0.4:0.1-0.4, more preferably 1:0.8-1.2:0.8-1.2:0.4-0.6:0.2-0.3:0.2-0.3. When the weight ratio of each extract is within the above range, the synergistic effect of the combined use of the cucumber grass extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract can be maximized.
예시적인 일 구현예에서, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물은 효과적인 항산화, 피부미백 및 피부주름 개선 효능을 제공하기에 바람직한 임의의 함량으로 조성물에 존재할 수 있다. 일 양태에 따르면, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물은 5 내지 200 ㎍/mL, 바람직하게는 5 내지 100 ㎍/mL, 더욱 바람직하게는 5 내지 50 ㎍/mL, 더욱 바람직하게는 5 내지 20 ㎍/mL 농도로 포함될 수 있다. 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 함량이 상기 범위의 미만인 경우에는 상기 혼합 추출물에 의한 효과를 기대하기 어려우며, 상기 범위를 초과하는 경우에는 함량의 증가에 따른 효과의 증가가 미미할 뿐만 아니라, 제형의 안정성이 저하되는 문제가 있다. 즉, 본 발명의 혼합 추출물이 조성물 내에 상기 범위로 포함됨으로써, 우수한 항산화, 피부미백 및 피부주름 개선 효과를 구현할 수 있고 제형 및 제품 안정성을 가지며 경제성 면에서도 최적의 함량으로 우수한 효과를 발휘할 수 있다. In an exemplary embodiment, the cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract may be present in the composition in any amount desired to provide effective antioxidant, skin whitening, and skin wrinkle improvement effects. You can. According to one embodiment, the cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract and buckwheat extract are used in an amount of 5 to 200 ㎍/mL, preferably 5 to 100 ㎍/mL, more preferably 5 to 50 ㎍/mL. It may be contained at a concentration of ㎍/mL, more preferably 5 to 20 ㎍/mL. If the content of the cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract and buckwheat extract is less than the above range, it is difficult to expect the effect of the mixed extract, and if it exceeds the above range, the content increases. Not only is the increase in effect negligible, but there is a problem that the stability of the formulation is reduced. In other words, by including the mixed extract of the present invention in the above range, it is possible to realize excellent antioxidant, skin whitening and skin wrinkle improvement effects, and has formulation and product stability, and can also exhibit excellent effects at the optimal content in terms of economic efficiency.
본 발명의 화장료 조성물은 상기 혼합 추출물 총 중량에 대하여 5 내지 15 중량부의 울금 추출물을 더 포함할 수 있다. 상기 울금 추출물이 상기 혼합 추출물 총 중량에 대하여 상기 중량비로 포함될 때, 항산화, 피부미백 및 피부주름 개선 효과가 더욱 좋아진다. 상기 혼합 추출물에 대한 울금 추출물의 함량이 상기 하한치 미만인 경우에는 울금 추출물의 첨가로 인한 효과가 미미해지고, 상기 상한치를 초과하는 경우에는 울금 추출물의 첨가로 인해 증가하는 항산화, 피부미백 및 피부주름 개선 효과가 오히려 낮아지는 문제점이 있다. 상기 울금 추출물은 특별히 제한되지는 않으나 오이풀 추출물과 동일한 방법으로 제조된 것일 수 있다.The cosmetic composition of the present invention may further include 5 to 15 parts by weight of turmeric extract based on the total weight of the mixed extract. When the turmeric extract is included in the weight ratio relative to the total weight of the mixed extract, the antioxidant, skin whitening, and skin wrinkle improvement effects are further improved. If the content of the turmeric extract in the mixed extract is less than the lower limit, the effect due to the addition of the turmeric extract becomes insignificant, and if it exceeds the upper limit, the antioxidant, skin whitening, and skin wrinkle improvement effects increase due to the addition of the turmeric extract. There is a problem in that it actually decreases. The turmeric extract is not particularly limited, but may be prepared in the same manner as the cucumber grass extract.
본 발명의 바람직한 양태에 따르면, 상기 항산화, 피부미백 및 피부주름 개선용 화장료 조성물의 제형은 화장수, 유액, 크림, 에센스, 화장 연고, 스프레이, 젤, 팩, 선 스크린, 메이크업 베이스, 파운데이션, 파우더 및 메이크업 제거제로 구성된 군으로부터 선택되는 것일 수 있다. According to a preferred embodiment of the present invention, the formulation of the cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement includes lotion, emulsion, cream, essence, cosmetic ointment, spray, gel, pack, sunscreen, makeup base, foundation, powder and It may be selected from the group consisting of makeup removers.
본 발명의 바람직한 양태에 따르면, 상기 항산화, 피부미백 및 피부주름 개선용 화장료 조성물은 상기 오이풀 추출물 또는 오이풀 추출물 함유 혼합 추출물 이외에 피부학적으로 허용가능한 부형제를 추가적으로 포함할 수 있다. According to a preferred embodiment of the present invention, the cosmetic composition for antioxidant, skin whitening, and skin wrinkle improvement may additionally include a dermatologically acceptable excipient in addition to the cucumber grass extract or a mixed extract containing cucumber grass extract.
상기 부형제로는 이에 한정되지는 않으나 예를 들어, 피부연화제, 피부 침투 증강제, 착색제, 방향제, 유화제, 농화제 및 용매를 포함할 수 있다. 또한, 향료, 색소, 살균제, 산화방지제, 방부제 및 보습제 등을 추가로 포함할 수 있으며, 물성개선을 목적으로 점증제, 무기염류, 합성 고분자 물질 등을 포함할 수 있다. The excipients are not limited thereto, but may include, for example, skin emollients, skin penetration enhancers, colorants, fragrances, emulsifiers, thickeners, and solvents. In addition, it may additionally contain fragrances, pigments, disinfectants, antioxidants, preservatives, and moisturizers, and may include thickeners, inorganic salts, synthetic polymer materials, etc. for the purpose of improving physical properties.
본 발명의 바람직한 양태에 따르면, 상기 보습제는 글리세린, 부틸렌글리콜, 프로필렌글리콜, 솔비톨, 헥실렌글리콜, 디프로필렌글리콜, 디글리세린, 1,2-헥산디올, 판테놀, 베타인, 스쿠알란, 바셀린, 유동파라핀 및 하이드롤라이즈드 밀 글루텐 중 선택된 1종 이상일 수 있으나, 이에 제한되는 것은 아니다.According to a preferred embodiment of the present invention, the moisturizing agent is glycerin, butylene glycol, propylene glycol, sorbitol, hexylene glycol, dipropylene glycol, diglycerin, 1,2-hexanediol, panthenol, betaine, squalane, petrolatum, liquid. It may be one or more selected from paraffin and hydrolyzed wheat gluten, but is not limited thereto.
본 발명의 화장료 조성물은 단독 또는 중복 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수 있다. 또한 본 발명에 따른 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다. The cosmetic composition of the present invention can be used alone or in multiple applications, or can be used in multiple applications with other cosmetic compositions other than the present invention. Additionally, the cosmetic composition according to the present invention can be used according to conventional usage methods, and the number of times of use can be varied depending on the user's skin condition or preference.
이하, 실시예에 의하여 본 발명을 상세히 설명하겠으나, 다음 실시예에 의해 본 발명이 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples, but the present invention is not limited to the following examples.
<실시예> <Example>
실시예 1-1: 오이풀 추출물의 제조 - 초음파 추출Example 1-1: Preparation of cucumber grass extract - ultrasonic extraction
오이풀의 뿌리(지유)를 잘 분쇄한 오이풀 분말을 준비하였다. Cucumber plant powder was prepared by pulverizing the roots (oil) of the cucumber plant.
오이풀 분말과 70% 에탄올 수용액을 1 : 20의 중량비로 혼합한 후 80 ℃에서 초음파추출기(내추럴솔루션; 120 kHz/30 min)로 3 시간 동안 추출하여 오이풀 에탄올 초음파 추출물을 수득하였다. 상기 수득된 추출물은 여과 및 감압 농축을 거쳐 동결건조로 분말화하였다. Cucumber grass powder and 70% ethanol aqueous solution were mixed at a weight ratio of 1:20, and then extracted for 3 hours at 80°C with an ultrasonic extractor (Natural Solution; 120 kHz/30 min) to obtain an ethanol ultrasonic extract of cucumber grass. The obtained extract was filtered, concentrated under reduced pressure, and powdered by freeze-drying.
실시예 1-2: 오이풀 추출물의 제조 - 초음파 추출+자외선 조사Example 1-2: Preparation of cucumber grass extract - ultrasonic extraction + ultraviolet irradiation
실시예 1-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 1-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 오이풀 분말을 자외선 처리를 위한 용기(350*255*40 ㎜)에 넣은 후 자외선 조사 장치(HD 2102.1, 2102.2, Delta OHM, 이탈리아)를 이용하여 용기 상단부에 자외선 UVB(300 nm)를 조사하였으며, 조사량이 100 mJ/㎡를 경과할 때마다 상기 용기를 뒤집어가며 혼합하였다. 이후, 총 자외선 UVB 조사량이 900 mJ/cm2이 되었을 때 자외선 조사를 중단하였다. The ultraviolet irradiation is performed by placing the cucumber powder in a container (350*255*40 mm) for ultraviolet treatment and then applying ultraviolet UVB (300 nm) to the top of the container using an ultraviolet irradiation device (HD 2102.1, 2102.2, Delta OHM, Italy). Irradiation was conducted, and the container was turned over and mixed every time the irradiation amount exceeded 100 mJ/㎡. Afterwards, UV irradiation was stopped when the total UVB irradiation amount reached 900 mJ/cm 2 .
실시예 2-1: 오이풀 추출물의 제조 - 열수 추출Example 2-1: Preparation of cucumber grass extract - hot water extraction
오이풀의 뿌리(지유)를 잘 분쇄한 오이풀 분말을 준비하였다. Cucumber plant powder was prepared by pulverizing the roots (oil) of the cucumber plant.
오이풀 분말과 정제수를 1 : 20의 중량비로 혼합한 후 90 ℃에서 3시간 동안 추출하여 오이풀 열수 추출물을 수득하였다. 상기 수득된 추출물은 여과 및 감압 농축을 거쳐 동결건조로 분말화하였다. Cucumber herb powder and purified water were mixed at a weight ratio of 1:20 and extracted at 90°C for 3 hours to obtain a cucumber herb hot water extract. The obtained extract was filtered, concentrated under reduced pressure, and powdered by freeze-drying.
실시예 2-2: 오이풀 추출물의 제조 - 열수 추출+자외선 조사Example 2-2: Preparation of cucumber grass extract - hot water extraction + ultraviolet irradiation
실시예 2-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 2-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 3-1: 오이풀 추출물 제조 - 발효 추출Example 3-1: Preparation of cucumber grass extract - fermentation extraction
오이풀의 뿌리(지유)를 잘 분쇄한 오이풀 분말을 준비하였다. Cucumber plant powder was prepared by pulverizing the roots (oil) of the cucumber plant.
그리고, 한국미생물보존센터로부터 수득한 락토바실러스 람노서스 HK-9(기탁번호: KCCM11254P)를 55%의 MRS 배지와 0.5% L-Cysteine hydrochloride를 첨가하여 제조한 배지가 있는 진탕항온배양기에 넣고, 50~60 rpm, 37 ℃에서 48 시간 동안 전배양하였다. Then, Lactobacillus rhamnosus HK-9 (accession number: KCCM11254P) obtained from the Korea Microorganism Conservation Center was placed in a shaking constant-temperature incubator with a medium prepared by adding 55% MRS medium and 0.5% L-Cysteine hydrochloride, and incubated for 50 minutes. Preculture was performed at ~60 rpm and 37°C for 48 hours.
2L 플라스크에 55% MRS 배지로 만든 유산균 배양 배지 1L 및 오이풀 분말 100g을 첨가하고, 상기 전배양된 3 × 109 cells/㎖ 농도의 락토바실러스 람노서스 HK-9 배양액을 5(v/v)% 접종한 후 37 ℃에서 48 시간 동안 발효하였다.To a 2L flask, 1L of lactic acid bacteria culture medium made from 55% MRS medium and 100g of cucumber grass powder were added, and the pre-cultured Lactobacillus rhamnosus HK-9 culture medium at a concentration of 3 × 109 cells/ml was added to 5(v/v)%. After inoculation, it was fermented at 37°C for 48 hours.
상기 발효물을 3,000 rpm에서 10 분 동안 원심분리하여 상등액을 취한 후 0.25 μM 여과지를 이용하여 여과하여 본 발명에 사용하였다. The fermented product was centrifuged at 3,000 rpm for 10 minutes to obtain the supernatant, which was then filtered using 0.25 μM filter paper and used in the present invention.
실시예 3-2: 오이풀 추출물 제조 - 발효 추출+자외선 조사Example 3-2: Preparation of cucumber grass extract - fermentation extraction + ultraviolet irradiation
실시예 3-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 3-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 4-1: 오이풀 혼합 추출물의 제조 - 초음파 추출Example 4-1: Preparation of mixed extract of cucumber grass - ultrasonic extraction
실시예 1-1과 동일한 방법으로 실시하되, 상기 오이풀 추출물과 동일한 방법으로 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 각각 추가하여 제조한 후, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 1 : 1 : 1 : 0.5 : 0.25 : 0.25의 중량비로 혼합하여 오이풀 혼합 추출물을 제조하였다. Carried out in the same manner as in Example 1-1, but prepared by adding mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract, respectively, in the same manner as the cucumber herb extract, the cucumber herb extract, mistletoe extract, A mixed extract of cucumber grass was prepared by mixing vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract at a weight ratio of 1:1:1:0.5:0.25:0.25.
실시예 4-2: 오이풀 혼합 추출물의 제조 - 초음파 추출+자외선 조사Example 4-2: Preparation of mixed extract of cucumber grass - ultrasonic extraction + ultraviolet irradiation
실시예 4-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 4-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 5-1: 오이풀 혼합 추출물의 제조 - 열수 추출Example 5-1: Preparation of mixed extract of cucumber grass - hot water extraction
실시예 1-1과 동일한 방법으로 실시하되, 상기 오이풀 추출물과 동일한 방법으로 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 각각 추가하여 제조한 후, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 1 : 1 : 1 : 0.5 : 0.25 : 0.25의 중량비로 혼합하여 오이풀 혼합 추출물을 제조하였다. Carried out in the same manner as in Example 1-1, but prepared by adding mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract, respectively, in the same manner as the cucumber herb extract, the cucumber herb extract, mistletoe extract, A mixed extract of cucumber grass was prepared by mixing vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract at a weight ratio of 1:1:1:0.5:0.25:0.25.
실시예 5-2: 오이풀 혼합 추출물의 제조 - 열수 추출Example 5-2: Preparation of mixed extract of cucumber grass - hot water extraction
실시예 5-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 5-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 6-1: 오이풀 혼합 추출물의 제조 - 발효 추출Example 6-1: Preparation of mixed extract of cucumber grass - fermentation extraction
실시예 1-1과 동일한 방법으로 실시하되, 상기 오이풀 추출물과 동일한 방법으로 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 각각 추가하여 제조한 후, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 1 : 1 : 1 : 0.5 : 0.25 : 0.25의 중량비로 혼합하여 오이풀 혼합 추출물을 제조하였다. Carried out in the same manner as in Example 1-1, but prepared by adding mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract, respectively, in the same manner as the cucumber herb extract, the cucumber herb extract, mistletoe extract, A mixed extract of cucumber grass was prepared by mixing vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract at a weight ratio of 1:1:1:0.5:0.25:0.25.
실시예 6-2: 오이풀 혼합 추출물의 제조 - 발효 추출+자외선 조사Example 6-2: Preparation of mixed extract of cucumber grass - fermentation extraction + ultraviolet irradiation
실시예 6-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 6-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 7-1: 오이풀 혼합 추출물(+울금)의 제조 - 초음파 추출Example 7-1: Preparation of cucumber grass mixed extract (+turmeric) - ultrasonic extraction
실시예 4-1과 동일한 방법으로 실시하되, 상기 오이풀 추출물과 동일한 방법으로 울금 추출물을 추가하여 제조한 후, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 혼합 추출물 100 중량부에 대하여 10 중량부의 울금 추출물을 혼합하여 오이풀 혼합 추출물을 제조하였다.Carried out in the same manner as in Example 4-1, but prepared by adding turmeric extract in the same manner as the cucumber extract, the cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract were mixed. A mixed extract of cucumber grass was prepared by mixing 10 parts by weight of turmeric extract with 100 parts by weight of the extract.
실시예 7-2: 오이풀 혼합 추출물(+울금)의 제조 - 초음파 추출+자외선 조사Example 7-2: Preparation of mixed extract of cucumber grass (+turmeric) - ultrasonic extraction + ultraviolet irradiation
실시예 7-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 7-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 8-1: 오이풀 혼합 추출물(+울금)의 제조 - 열수 추출Example 8-1: Preparation of cucumber grass mixed extract (+turmeric) - hot water extraction
실시예 5-1과 동일한 방법으로 실시하되, 상기 오이풀 추출물과 동일한 방법으로 울금 추출물을 추가하여 제조한 후, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 혼합 추출물 100 중량부에 대하여 10 중량부의 울금 추출물을 혼합하여 오이풀 혼합 추출물을 제조하였다.Carried out in the same manner as in Example 5-1, but prepared by adding turmeric extract in the same manner as the cucumber extract, the cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract were mixed. A mixed extract of cucumber grass was prepared by mixing 10 parts by weight of turmeric extract with 100 parts by weight of the extract.
실시예 8-2: 오이풀 혼합 추출물(+울금)의 제조 - 열수 추출+자외선 조사Example 8-2: Preparation of cucumber grass mixed extract (+turmeric) - hot water extraction + ultraviolet irradiation
실시예 8-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 8-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
실시예 9-1: 오이풀 혼합 추출물(+울금)의 제조 - 발효 추출Example 9-1: Preparation of cucumber grass mixed extract (+turmeric) - fermentation extraction
실시예 6-1과 동일한 방법으로 실시하되, 상기 오이풀 추출물과 동일한 방법으로 울금 추출물을 추가하여 제조한 후, 상기 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물의 혼합 추출물 100 중량부에 대하여 10 중량부의 울금 추출물을 혼합하여 오이풀 혼합 추출물을 제조하였다.Carried out in the same manner as in Example 6-1, but prepared by adding turmeric extract in the same manner as the cucumber extract, then mixed with the cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract. A mixed extract of cucumber grass was prepared by mixing 10 parts by weight of turmeric extract with 100 parts by weight of the extract.
실시예 9-2: 오이풀 혼합 추출물(+울금)의 제조 - 발효 추출+자외선 조사Example 9-2: Preparation of mixed extract of cucumber grass (+turmeric) - fermentation extraction + ultraviolet irradiation
실시예 9-1과 동일한 방법으로 실시하되, 상기 오이풀 분말은 추출 전에 자외선 조사를 수행하여 오이풀 추출물을 제조하였다. Cucumber grass extract was prepared in the same manner as in Example 9-1, except that the cucumber grass powder was irradiated with ultraviolet rays before extraction.
상기 자외선 조사는 실시예 1-2와 동일한 방법으로 실시하였다. The ultraviolet irradiation was performed in the same manner as Example 1-2.
<시험예> < Test example>
통계 처리statistical processing
모든 통계 분석은 SPSS 버전 18.0(IBM, Chicago, IL, USA)을 사용하여 수행되었다. Duncan의 post-hoc test를 이용한 일원 분산 분석(one-way ANOVA)을 사용하여 실험군 간의 평균값의 차이(p <0.05)를 결정하였다. 하기 실험은 각각 적어도 3번 이상 반복하였으며, 각각의 실험데이터는 평균 ± 표준 편차(SD)로 표시하였다.All statistical analyzes were performed using SPSS version 18.0 (IBM, Chicago, IL, USA). Differences in mean values between experimental groups (p <0.05) were determined using one-way ANOVA with Duncan's post-hoc test. The following experiments were each repeated at least three times, and each experimental data was expressed as mean ± standard deviation (SD).
시험예 1: MTT assay를 이용한 세포독성 평가Test Example 1: Cytotoxicity evaluation using MTT assay
세포 독성은 MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)환원 방법을 이용하여 측정하였다.Cytotoxicity was measured using the MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) reduction method.
배양된 HaCaT 세포를 DMEM 배지에 잘 혼합한 후 1x105 cells/mL로 조정한 다음, 24-well 배양판에 준비된 세포를 1 mL씩 첨가한 후 3-4일 배양하였다. 세포가 80% 정도 성장했을 때 우태아 혈청과 항생제를 첨가하지 않은 배지에 다양한 농도의 시료(50, 100, 200 및 500 ㎍/mL)로 처리한 후, 24시간 더 배양을 하고, 배양이 끝난 세포의 생존율은 MTT 환원 방법을 이용하여 측정하였다.Cultured HaCaT cells were mixed well in DMEM medium and adjusted to 1x10 5 cells/mL, then 1 mL of prepared cells were added to a 24-well culture plate and cultured for 3-4 days. When the cells had grown to about 80%, they were treated with samples of various concentrations (50, 100, 200, and 500 ㎍/mL) in medium without fetal bovine serum and antibiotics, and then cultured for an additional 24 hours, and at the end of the culture. Cell viability was measured using the MTT reduction method.
각 well에 MTT 용액(5 mg/mL)을 성장배지 부피의 10분의 1 가량 가한 후, 다시 37 ℃에서 4시간 더 배양하였다. 그리고, MTT를 환원시켜 생성된 formazan이 배지에 따라 나가지 않도록 조심하며 배지를 제거하고, 남아 있는 배지를 완전히 제거하기 위해 실온에서 30분간 방치한 후 DMSO를 이용하여 시료를 용해시킨 다음 570 nm에서 흡광도를 측정하였다. 세포 생존율은 하기 수학식 1과 같이 계산한 후, 하기 표 1에 나타내었다.Approximately one-tenth of the volume of the growth medium was added with MTT solution (5 mg/mL) to each well, and then cultured at 37°C for another 4 hours. Then, remove the medium, being careful not to let the formazan produced by reducing MTT go out into the medium. After leaving it at room temperature for 30 minutes to completely remove the remaining medium, dissolve the sample using DMSO, and measure the absorbance at 570 nm. was measured. Cell survival rate was calculated according to Equation 1 below and is shown in Table 1 below.
[수학식 1][Equation 1]
세포 생존율(%) = (시료처리군의 흡광도 / 대조군의 흡광도) × 100Cell viability (%) = (absorbance of sample treatment group / absorbance of control group) × 100
상기 표 1에 나타낸 바와 같이, 본 발명의 실시예에 따른 시료는 인간 피부에 안전하게 사용될 수 있음을 확인하였다. As shown in Table 1 above, it was confirmed that the samples according to the examples of the present invention can be safely used on human skin.
시험예 2: 항산화 활성Test Example 2: Antioxidant activity
2-1: DPPH 라디칼 소거능2-1: DPPH radical scavenging ability
시험물질을 증류수에 녹인 후, 다양한 농도로 희석한 시험액을 준비하였다.After dissolving the test substance in distilled water, test solutions diluted to various concentrations were prepared.
96-well plate에 다양한 농도로 희석한 시험액 100 μL와 0.15 mM DPPH (2,2-diphenyl-1-picrylhydrazyl) 용액 100 μL을 넣고 혼합하여 실온에 30분간 반응시킨 후 570 nm 파장에서 흡광도를 측정하였다. 결과 값은 시료를 첨가하지 않은 대조군과 비교하여 유리 라디칼의 제거 활성을 나타냈으며, 양성대조군으로는 ascorbic acid를 사용하였다. DPPH radical 소거능은 아래의 식으로 산출하였고, SC50값은 각 농도별 radical 소거능에 대한 검량선에서 radical 소거능이 50%가 되는 농도를 계산하여 하기 표 2에 나타내었다. 참고로, 양성대조군인 Ascorbic acid의 경우 DPPH 라디칼 소거능(%)이 6.25, 12.5 및 25 ㎍/mL 농도에서 각각 15.8±1.9%, 60.9±1.9% 및 83.4±0.8%이었고, SC50은 11.7±0.4 ㎍/mL이었다.100 μL of the test solution diluted to various concentrations and 100 μL of 0.15 mM DPPH (2,2-diphenyl-1-picrylhydrazyl) solution were added to a 96-well plate, mixed, and reacted at room temperature for 30 minutes, and then the absorbance was measured at a wavelength of 570 nm. . The results showed the removal activity of free radicals compared to the control group to which no sample was added, and ascorbic acid was used as the positive control group. DPPH radical scavenging ability was calculated using the formula below, and the SC 50 value was calculated from the concentration at which the radical scavenging ability is 50% from the calibration curve for the radical scavenging ability at each concentration and is shown in Table 2 below. For reference, in the case of ascorbic acid, a positive control, the DPPH radical scavenging ability (%) was 15.8 ± 1.9%, 60.9 ± 1.9%, and 83.4 ± 0.8% at concentrations of 6.25, 12.5, and 25 ㎍/mL, respectively, and SC 50 was 11.7 ± 0.4. It was ㎍/mL.
[수학식 2][Equation 2]
DPPH 라디칼 소거능(%) = (1-A/B) x 100DPPH radical scavenging ability (%) = (1-A/B) x 100
(A: 시료 첨가구의 흡광도, B: 무처리구의 흡광도)(A: Absorbance of sample addition section, B: Absorbance of untreated section)
(㎍/mL)SC 50
(㎍/mL)
상기 표 2에 나타낸 바와 같이, 실시예에 따른 추출물이 우수한 항산화 효과를 나타내는 것을 확인할 수 있다. As shown in Table 2, it can be confirmed that the extract according to the example shows excellent antioxidant effect.
시험예 3: 미백 효과Test Example 3: Whitening effect
3-1: 티로시나제 활성 저해능3-1: Tyrosinase activity inhibition ability
Tyrosine을 수산화 (hydroxylation)하여 3,4-dihydroxyphenylalanine (DOPA)로 변화하는 tyrosinase의 tyrosine hydroxylase 활성 저해능을 평가하였다. 시험물질을 증류수로 녹이고 0.1 M phosphate buffer (pH 6.5)에 희석하여 다양한 농도의 시험액을 각각 준비하였다. 96-well plate에 0.1 M phosphate buffer (pH 6.5) 170 μL, 다양한 농도로 희석한 시험액 10 μL, 2000 unit/mL mushroom tyrosinase 10 μL 및 1.5 mM L-tyrosine 10 μL를 순차적으로 넣은 후 혼합하여 37℃에서 15분 동안 반응시킨 후 490 nm 파장에서 흡광도를 측정하였다. 공시험액의 흡광도는 시험액 대신 0.1 M phosphate buffer (pH 6.5)를 넣어 동일한 방법으로 반응하여 측정하였다. 티로시나제 효소 활성 억제율은 아래의 식으로 산출하여 하기 표 3에 나타내었다.The ability to inhibit tyrosine hydroxylase activity of tyrosinase, which hydroxylates tyrosine to 3,4-dihydroxyphenylalanine (DOPA), was evaluated. The test substances were dissolved in distilled water and diluted in 0.1 M phosphate buffer (pH 6.5) to prepare test solutions of various concentrations. In a 96-well plate, sequentially add 170 μL of 0.1 M phosphate buffer (pH 6.5), 10 μL of test solution diluted to various concentrations, 10 μL of 2000 unit/mL mushroom tyrosinase, and 10 μL of 1.5 mM L-tyrosine, then mix and cool at 37°C. After reacting for 15 minutes, absorbance was measured at a wavelength of 490 nm. The absorbance of the blank test solution was measured by reacting in the same manner by adding 0.1 M phosphate buffer (pH 6.5) instead of the test solution. The inhibition rate of tyrosinase enzyme activity was calculated using the formula below and is shown in Table 3 below.
[수학식 3][Equation 3]
효소 활성 억제율 (%) = {(A-B)/A} x 100Enzyme activity inhibition rate (%) = {(A-B)/A} x 100
(A: 공시험액의 반응 후 흡광도, B: 시험액의 반응 후 흡광도)(A: Absorbance after reaction of blank test solution, B: Absorbance after reaction of test solution)
상기 표 3에 나타낸 바와 같이, 실시예에 따른 추출물의 티로시나제 억제 효과가 매우 우수한 것으로 확인되었다.As shown in Table 3, the tyrosinase inhibitory effect of the extract according to the example was confirmed to be very excellent.
3-2: 멜라민 합성 저해능3-2: Melamine synthesis inhibition ability
B16F10 세포 배양B16F10 cell culture
생쥐에서 유래한 흑색종 세포인 B16F10 세포는 Dulbecco's modified Eagle's medium (DMEM, Gibco-Invitrogen, carlabad, CA, USA)에 10% fetal bovine serum(FBS), 100 units/mL penicillin과 100 μg/mL streptomycin을 첨가한 세포배양액을 사용하여 37℃ 습윤한 CO2 배양기 (5% CO2/95% air)에서 배양하였다. 세포가 배양접시의 80% 정도 찼을 때, phosphate buffer saline (PBS, pH 7.4)으로 세포 단층을 씻어낸 후 세포배양액을 첨가하여 세포를 떼어내어 계대 배양하였고, 배지는 2일마다 교환하였다.B16F10 cells, melanoma cells derived from mice, were grown in Dulbecco's modified Eagle's medium (DMEM, Gibco-Invitrogen, Carlabad, CA, USA) with 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 μg/mL streptomycin. The added cell culture medium was used to culture in a humid CO 2 incubator (5% CO 2 /95% air) at 37°C. When the culture dish was about 80% filled with cells, the cell monolayer was washed with phosphate buffer saline (PBS, pH 7.4), cell culture medium was added, cells were detached and subcultured, and the medium was changed every two days.
B16F10 세포에서 생성된 melanin 함량 측정Measurement of melanin content produced in B16F10 cells
B16F10 세포를 5 × 104 cells/well이 되도록 12-well plate에 분주하여 24시간 동안 배양하였다. 세포를 24시간 배양한 후 100 nM α-melanocyte-stimulating hormone (α-MSH, Sigma-Aldrich) 및 다양한 농도의 시험물질을 함유한 배양액으로 세포배양액을 교환하여 세포를 배양하였다. 72시간 동안 세포를 배양한 후 세포 단층을 PBS로 세척한 후 0.25% trypsin-2.65 mM EDTA를 처리하여 세포를 회수하였고, 12,000 rpm에서 10분간 원심분리하여 pellet을 얻었다. 획득한 pellet에 10% dimethylsulfoxide (DMSO)를 함유된 1 N NaOH를 넣어 60℃에서 용해시킨 후 490 nm 파장에서 흡광도를 측정하였다. 합성 melanin을 이용한 검량선으로부터 melanin의 양을 산출하였고, BCA protein assay kit (Thermo Scientific)을 사용하여 단백질을 측정하여 melanin 생성량을 단백질 양으로 표준화한 후 α-MSH 만을 처리한 군의 값을 100으로 하여 상대적인 값으로 나타내었다. 이때 양성대조군은 α-MSH 100 nM만을 처리한 시험군이고, 비교군은 TGF-β1 10 ng/mL를 처리한 시험군이다. 참고로, α-MSH 및 시료를 모두 처리하지 않은 무처리군의 멜라닌 함량은 61.1±8.8%로 측정되었다.B16F10 cells were distributed in a 12-well plate at 5 × 10 4 cells/well and cultured for 24 hours. After culturing the cells for 24 hours, the cell culture medium was exchanged with a culture medium containing 100 nM α-melanocyte-stimulating hormone (α-MSH, Sigma-Aldrich) and various concentrations of test substances. After culturing the cells for 72 hours, the cell monolayer was washed with PBS, treated with 0.25% trypsin-2.65 mM EDTA to recover the cells, and centrifuged at 12,000 rpm for 10 minutes to obtain a pellet. 1 N NaOH containing 10% dimethylsulfoxide (DMSO) was added to the obtained pellet to dissolve it at 60°C, and the absorbance was measured at a wavelength of 490 nm. The amount of melanin was calculated from a calibration curve using synthetic melanin, and the protein was measured using a BCA protein assay kit (Thermo Scientific). The amount of melanin produced was normalized to the amount of protein, and the value of the group treated only with α-MSH was set to 100. Expressed as a relative value. At this time, the positive control group is a test group treated with only 100 nM of α-MSH, and the comparison group is a test group treated with 10 ng/mL of TGF-β1. For reference, the melanin content of the untreated group in which neither α-MSH nor the sample was treated was measured to be 61.1 ± 8.8%.
상기 표 4에 나타낸 바와 같이, 실시예에 따른 추출물의 멜라닌 합성 억제 효과가 매우 우수한 것으로 확인되었다.As shown in Table 4, the melanin synthesis inhibition effect of the extract according to the example was confirmed to be very excellent.
시험예 4: 피부주름 개선 효과Test Example 4: Skin wrinkle improvement effect
4-1: 타입 1 프로콜라겐 단백질의 합성 촉진4-1: Promotes synthesis of type 1 procollagen protein
HS68 세포 배양HS68 cell culture
인간에서 유래한 피부 섬유아세포인 HS68 세포는 한국세포주은행에서 구입하여 사용하였다. HS68 세포는 DMEM 배지 (Welgene)에 10% fetal bovine serum (FBS), 100 units/mL penicillin과 100 μg/mL streptomycin을 첨가한 세포배양액 (complete DMEM 배양액)을 사용하여 37℃ 습윤한 CO2 배양기 (5% CO2/95% air)에서 배양하였다. 세포가 배양접시의 80% 정도 찼을 때, phosphate buffer saline (PBS, pH 7.4)으로 세포 단층을 씻어낸 후 trypsin-2.65 mM EDTA를 첨가하여 세포를 떼어내어 계대 배양하였고, 배지는 2일마다 교환하였다.HS68 cells, human-derived skin fibroblasts, were purchased from the Korea Cell Line Bank. HS68 cells were grown in DMEM medium (Welgene) using cell culture medium (complete DMEM medium) supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 μg/mL streptomycin, and incubated at 37°C in a humidified CO2 incubator (5 % CO2/95% air). When the culture dish was about 80% filled with cells, the cell monolayer was washed with phosphate buffer saline (PBS, pH 7.4), trypsin-2.65mM EDTA was added, cells were detached and subcultured, and the medium was changed every 2 days. .
HS68 세포가 생성 분비한 타입 1 프로콜라겐 함량 측정Measurement of type 1 procollagen content produced and secreted by HS68 cells
HS68 세포를 1 × 105 cells/well이 되도록 24-well plate에 분주하고 24시간 세포를 배양하였다. 세포를 24시간 배양한 후 각각의 시험물질을 다양한 농도로 함유한 serum-free 세포배양액으로 교환하여 세포를 24시간 배양하였다. 세포를 24시간 배양한 후 세포배양액을 수거하여 Procollagen Type I C-Peptide (PIP) EIA Kit (Takara)를 사용하여 제조사에서 제시한 방법에 따라 프로콜라겐 (procollagen) 타입 I C-펩타이드 (PICP) 함량을 측정하여 하기 표 5에 나타내었다. 이때 비교군은 TGF-β1 10 ng/mL를 처리한 시험군이다. 참고로, 시료를 처리하지 않은 무처리군의 타입 1 프로콜라겐 함량은 280.0±0.4 ng/mL로 측정되었다.HS68 cells were distributed in a 24-well plate at 1 × 10 5 cells/well and the cells were cultured for 24 hours. After culturing the cells for 24 hours, they were replaced with serum-free cell culture medium containing various concentrations of each test substance, and the cells were cultured for 24 hours. After culturing the cells for 24 hours, the cell culture medium was collected and the procollagen type I C-peptide (PICP) content was measured according to the method suggested by the manufacturer using the Procollagen Type I C-Peptide (PIP) EIA Kit (Takara). was measured and shown in Table 5 below. At this time, the comparison group was a test group treated with 10 ng/mL of TGF-β1. For reference, the type 1 procollagen content of the untreated group was measured to be 280.0 ± 0.4 ng/mL.
상기 표 5에 나타낸 바와 같이, 실시예에 따른 추출물이 타입 1 프로콜라겐의 생성을 촉진시키는 작용을 통해 주름 생성을 효과적으로 예방하고, 생성된 주름을 개선하는 효과가 있음을 확인할 수 있다. As shown in Table 5, it can be confirmed that the extract according to the example effectively prevents the formation of wrinkles and improves the formed wrinkles by promoting the production of type 1 procollagen.
4-2: MMP-1 단백질의 합성 저해4-2: Inhibition of synthesis of MMP-1 protein
HS68 세포를 1 × 105 cells/well이 되도록 24-well plate에 분주하고 24시간 세포를 배양하였다. 세포를 24시간 배양한 후 각각의 시험물질을 다양한 농도로 함유한 serum-free 세포배양액으로 교환하여 세포를 24시간 배양하였다. 세포를 24시간 배양한 후 세포배양액을 수거하여 Human MMP-1 ELISA Kit (Sigma-Aldrich)를 사용하여 제조사에서 제시한 방법에 따라 MMP-1 함량을 측정하여 하기 표 6에 나타내었다. 참고로, 시료를 처리하지 않은 무처리군의 MMP-1 함량은 4.21±0.10 ng/mL로 측정되었다. HS68 cells were distributed in a 24-well plate at 1 × 10 5 cells/well and the cells were cultured for 24 hours. After culturing the cells for 24 hours, they were replaced with serum-free cell culture medium containing various concentrations of each test substance, and the cells were cultured for 24 hours. After culturing the cells for 24 hours, the cell culture medium was collected and the MMP-1 content was measured using the Human MMP-1 ELISA Kit (Sigma-Aldrich) according to the method suggested by the manufacturer, and is shown in Table 6 below. For reference, the MMP-1 content of the untreated group was measured to be 4.21 ± 0.10 ng/mL.
상기 표 6에 나타낸 바와 같이, 실시예에 따른 추출물이 MMP-1 발현을 억제하는 작용을 통해 주름 생성을 효과적으로 예방하고, 생성된 주름을 개선하는 효과가 있음을 확인할 수 있다. As shown in Table 6, it can be confirmed that the extract according to the example effectively prevents the formation of wrinkles and improves the wrinkles formed through the action of suppressing MMP-1 expression.
시험예 5: 인체 첩포 시험Test Example 5: Human patch test
인체 첩포시험은 헬싱키 선언에 근거한 윤리규정 및 식품의약품안전처 화장품 인체적용시험가이드라인에 따라 실시되었으며, Frosch & Kligman이 고안한 방법(J. Am. Acad. Dermatol, 1(1) 35 (1979))을 응용하여 특정 피부질환 및 알레르기가 없는 20세 ~ 60세의 건강한 여성 피험자 32명(평균연령 41.34±8.06세)을 대상으로 실시하였다. 먼저, 첩포 부위를 70% ethanol로 소독한 후 실시예 1 내지 9의 시료(200 ㎍/mL) 20 ㎕가 적용된 Van der Bend (Van der Bend, Netherlands)를 첩포하였다. 48 h 후 첩포를 제거하고 skin marker (Chemotechnique Diagnostics AB, Sweden)로 시험 부위를 표시하였으며, 20 min, 24 h 후에 각 시험 부위의 반응도를 평가하였다. 일차 피부자극 시험(Skin Primary irritation Test)의 평가 기준은 하기 표 7에 제시한 PCPC Guidelines의 판정 기준에 따랐으며, 2회에 걸쳐 평가한 피부 반응의 정도(평균 반응도)를 하기 수학식 4에 따라 점수화하였다.The human patch test was conducted in accordance with the ethical regulations based on the Declaration of Helsinki and the Ministry of Food and Drug Safety Cosmetics Human Application Testing Guidelines, using the method devised by Frosch & Kligman (J. Am. Acad. Dermatol, 1(1) 35 (1979) ) was applied to 32 healthy female subjects aged 20 to 60 (mean age 41.34 ± 8.06 years) without specific skin diseases or allergies. First, the patch area was disinfected with 70% ethanol, and then a Van der Bend (Van der Bend, Netherlands) patch containing 20 μl of the samples (200 μg/mL) of Examples 1 to 9 was applied. After 48 h, the patch was removed, the test site was marked with a skin marker (Chemotechnique Diagnostics AB, Sweden), and the reactivity of each test site was evaluated after 20 min and 24 hours. The evaluation criteria for the primary skin irritation test were in accordance with the PCPC Guidelines shown in Table 7 below, and the degree of skin reaction (average reactivity) evaluated twice was calculated according to Equation 4 below: Scored.
[수학식 4][Equation 4]
평균반응도 = [{(반응도 × 반응이 나타난 피검자수)/(총피검자수 × 최고점수(5점))} × 100] × 1/2Average reactivity = [{(reactivity × number of subjects who responded)/(total number of subjects × highest score (5 points))} × 100] × 1/2
인체 피부에서의 피부 자극 정도를 평가하기 위하여 액상 상태의 실시예 1 내지 9의 시료 20 μL를 각각 32명의 피험자에 첩포하여 인체 첩포 시험을 실시하고, 그 결과를 하기 표 8에 나타내었다. In order to evaluate the degree of skin irritation on human skin, a human patch test was performed by applying 20 μL of the samples of Examples 1 to 9 in liquid state to each of 32 subjects, and the results are shown in Table 8 below.
상기 표 8을 살펴보면, 본 발명의 실시예에 따른 시료를 첩포하여 피부 자극 정도를 평가한 결과 32명의 피험자가 모두 반응 등급이 0.0으로서 음성 반응을 나타냈으므로, 본 발명의 조성물은 인체 피부 일차 자극 측면에서 무자극 물질로 판단된다. Looking at Table 8, as a result of evaluating the degree of skin irritation by applying the sample according to the example of the present invention, all 32 subjects showed a negative reaction with a reaction grade of 0.0, so the composition of the present invention is a primary irritant to human skin. From this perspective, it is considered a non-irritating material.
하기 본 발명의 오이풀 추출물을 위한 제조예를 예시한다.The following illustrates a preparation example for the cucumber grass extract of the present invention.
<제조예> 화장품의 제조<Manufacture example> Manufacture of cosmetics
제조예 1: 유연화장수(스킨)Preparation Example 1: Soft lotion (skin)
본 발명의 오이풀 추출물을 포함하는 항산화, 피부미백 및 피부주름 개선용 유연화장수를 제조하기 위해 하기 표 9에 기재된 것처럼 배합하여 통상적인 화장품 분야에서의 제조방법에 따라 제조할 수 있다. To prepare an antioxidant, skin whitening, and skin wrinkle-improving softening lotion containing the cucumber grass extract of the present invention, it can be mixed as shown in Table 9 below and manufactured according to a conventional manufacturing method in the cosmetics field.
제조예 2: 영양화장수(로션)Manufacturing Example 2: Nutritional lotion (lotion)
본 발명의 오이풀 추출물을 포함하는 항산화, 피부미백 및 피부주름 개선용 영양화장수를 제조하기 위해 하기 표 10에 기재된 것처럼 배합하여 통상적인 화장품 분야에서의 제조방법에 따라 제조할 수 있다.To prepare a nutritional lotion containing the cucumber grass extract of the present invention for antioxidant, skin whitening, and skin wrinkle improvement, it can be mixed as shown in Table 10 below and manufactured according to a conventional manufacturing method in the cosmetics field.
제조예 3: 영양크림Manufacturing Example 3: Nutritional cream
본 발명의 오이풀 추출물을 포함하는 항산화, 피부미백 및 피부주름 개선용 영양크림을 제조하기 위해 하기 표 11에 기재된 것처럼 배합하여 통상적인 화장품 분야에서의 제조방법에 따라 제조할 수 있다.To prepare a nutritional cream for antioxidant, skin whitening and skin wrinkle improvement containing the cucumber grass extract of the present invention, it can be mixed as shown in Table 11 below and manufactured according to a conventional manufacturing method in the cosmetics field.
제조예 4: 마스크 팩용 유액Preparation Example 4: Emulsion for mask pack
본 발명의 오이풀 추출물을 포함하는 항산화, 피부미백 및 피부주름 개선용 마스크팩용 유액을 제조하기 위해 하기 표 12에 기재된 것처럼 배합하여 통상적인 화장품 분야에서의 제조방법에 따라 제조할 수 있다.To prepare a mask pack emulsion for antioxidant, skin whitening and skin wrinkle improvement containing the cucumber plant extract of the present invention, it can be mixed as shown in Table 12 below and prepared according to a conventional manufacturing method in the cosmetics field.
비록 본 발명이 상기에 언급된 바람직한 실시예로서 설명되었으나, 발명의 요지와 범위로부터 벗어남이 없이 다양한 수정이나 변형을 하는 것이 가능하다. 또한, 첨부된 특허청구범위는 본 발명의 요지에 속하는 이러한 수정이나 변형을 포함한다.Although the present invention has been described in terms of the above-mentioned preferred embodiments, various modifications and variations can be made without departing from the gist and scope of the invention. Additionally, the appended claims cover such modifications or variations as fall within the subject matter of the present invention.
Claims (7)
상기 추출물은 오이풀에 자외선 UVB를 350 ~ 1000 mJ/cm2로 조사한 후 추출한 추출물인 것을 특징으로 하는 항산화, 피부미백 및 피부주름 개선용 화장료 조성물. Contains cucumber plant extract as an active ingredient,
A cosmetic composition for antioxidant, skin whitening and skin wrinkle improvement, characterized in that the extract is an extract extracted after irradiating cucumber grass with ultraviolet UVB at 350 to 1000 mJ/cm 2 .
상기 추출물은 열수 추출물, 초음파 추출물 또는 락토바실러스속 유산균 발효물의 추출물인 것을 특징으로 하는 화장료 조성물. According to paragraph 1,
A cosmetic composition, characterized in that the extract is a hot water extract, an ultrasonic extract, or an extract of fermented lactic acid bacteria of the Lactobacillus genus.
상기 조성물은 상기 추출물을 5 내지 200 ㎍/mL 농도로 포함하는 것을 특징으로 하는 화장료 조성물.According to paragraph 1,
A cosmetic composition comprising the extract at a concentration of 5 to 200 μg/mL.
상기 조성물은 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물을 더 포함하는 것을 특징으로 하는 화장료 조성물. According to paragraph 1,
The cosmetic composition further comprises mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract, and buckwheat extract.
상기 조성물은 오이풀 추출물, 겨우살이 추출물, 비타민나무열매 추출물, 오미자 추출물, 토마토 추출물 및 메밀 추출물이 1 : 0.5-2.0 : 0.5-2.0 : 0.1-1.5 : 0.05-1.0 : 0.05-1.0의 중량비로 포함된 것을 특징으로 하는 화장료 조성물.According to clause 5,
The composition contains cucumber extract, mistletoe extract, vitamin tree fruit extract, Schisandra chinensis extract, tomato extract and buckwheat extract in a weight ratio of 1: 0.5-2.0: 0.5-2.0: 0.1-1.5: 0.05-1.0: 0.05-1.0. Characterized cosmetic composition.
상기 조성물은 상기 추출물 총 중량에 대하여 5 내지 15 중량부의 울금 추출물을 더 포함하는 것을 특징으로 하는 화장료 조성물.According to clause 6,
The cosmetic composition further comprises 5 to 15 parts by weight of turmeric extract based on the total weight of the extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200171821A KR102632084B1 (en) | 2020-12-10 | 2020-12-10 | Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200171821A KR102632084B1 (en) | 2020-12-10 | 2020-12-10 | Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220082192A KR20220082192A (en) | 2022-06-17 |
KR102632084B1 true KR102632084B1 (en) | 2024-02-02 |
Family
ID=82269056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200171821A KR102632084B1 (en) | 2020-12-10 | 2020-12-10 | Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102632084B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102641387B1 (en) * | 2023-10-13 | 2024-02-28 | 주식회사 미산 | Cosmetic composition containing plant extracts having skin moisturizing Effect, a preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101020536B1 (en) | 2008-05-09 | 2011-03-09 | (주)더페이스샵 | Moisturizing cosmetic composition containing extract of Sanguisorba officinalis and method of producing the same |
WO2014103475A1 (en) * | 2012-12-27 | 2014-07-03 | 株式会社林原 | Skin-exterior anti-ageing composition and production method therefor |
KR102133074B1 (en) | 2017-06-30 | 2020-07-10 | 배재대학교 산학협력단 | A cosmetic composition containing cold water extract or its ethyl acetate fraction from Sanguisorba officinalis having specific anti-microbial activity against acne-inducing bacterium |
KR20190092800A (en) * | 2018-01-31 | 2019-08-08 | 동신대학교산학협력단 | Composition for improving skin photo-aging |
-
2020
- 2020-12-10 KR KR1020200171821A patent/KR102632084B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220082192A (en) | 2022-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101971837B1 (en) | Cosmetic composition for improving skin whitening and wrinkle comprising adventitious root extract of Centella asiatica as effective component | |
KR20110076043A (en) | Cosmetic composition comprising smilax china as active ingredient | |
KR20100130878A (en) | Cosmetic composition comprising plant extracts | |
KR101071414B1 (en) | Composition for Whitening Containing Extract of Annona muricata as an active ingredient | |
KR102632084B1 (en) | Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
KR100515419B1 (en) | Whitening cosmetics composition comprising natural herb extracts | |
KR101323068B1 (en) | Cosmetic composition comprising the extract of Viburnum odoratissimum var. awabuki as active ingredient | |
KR102628844B1 (en) | Cosmetic composition for anti-oxidation, skin whitening and anti-wrinkle containing a mixed fermentation extracts of Wisteria floribunda flowers, Aralia elata flowers, Camellia japonica leafs and Camellia japonica flowers as effective component | |
KR101317433B1 (en) | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage | |
KR101207560B1 (en) | Cosmetic composition comprising the extract of Cleyera japonica as active ingredient | |
KR101176525B1 (en) | Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient | |
KR101083029B1 (en) | A cosmetic composition containing rice germ and Coptis chinensis extracts for absorbing Ultraviolet | |
CN113631227A (en) | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic | |
KR20200046674A (en) | A composition for antioxidating, whitening and improving wrinkle comprising extracts of black persimmon | |
KR101515443B1 (en) | The functional cosmetic composition for anti-wrinkle, skin whitening and recovery of distrupted skin containing, comprising the mixture of extract of bergamot, Lonicera japonica Thunberg, Coix lachryma-jobi var. mayuen and wheat bud | |
KR101153320B1 (en) | Cosmetic composition | |
KR20100043717A (en) | Composition for whitening containing extract of ixora coccinea | |
KR101068808B1 (en) | Composition for Whitening Containing Extract of Delonix regia | |
KR100930592B1 (en) | Skin whitening and antioxidant composition containing extracts against | |
KR20110032670A (en) | Composition for improving skin containing callus of broussonetia plant | |
KR20170137432A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR101922131B1 (en) | Composition for skin-whitener containing extract of stauntonia hexaphylla | |
KR20170136917A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR101207559B1 (en) | Cosmetic composition comprising the extract of Pourthiaea villosa as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |